DE MONTE, MATTEO
 Distribuzione geografica
Continente #
AS - Asia 135
NA - Nord America 100
EU - Europa 66
SA - Sud America 13
AF - Africa 5
OC - Oceania 1
Totale 320
Nazione #
US - Stati Uniti d'America 91
SG - Singapore 41
CN - Cina 35
IT - Italia 34
HK - Hong Kong 18
BD - Bangladesh 16
BR - Brasile 12
VN - Vietnam 10
NL - Olanda 7
CA - Canada 6
DE - Germania 5
RU - Federazione Russa 5
FR - Francia 4
IN - India 4
CI - Costa d'Avorio 3
FI - Finlandia 3
ID - Indonesia 2
JP - Giappone 2
KR - Corea 2
PL - Polonia 2
TR - Turchia 2
AL - Albania 1
AR - Argentina 1
AT - Austria 1
AU - Australia 1
CH - Svizzera 1
EG - Egitto 1
GB - Regno Unito 1
IQ - Iraq 1
JM - Giamaica 1
MA - Marocco 1
MD - Moldavia 1
MX - Messico 1
PA - Panama 1
PH - Filippine 1
SE - Svezia 1
TW - Taiwan 1
Totale 320
Città #
Singapore 25
Hong Kong 16
San Jose 16
Ashburn 15
Boardman 6
Los Angeles 6
Beijing 5
Council Bluffs 5
Hefei 4
Ho Chi Minh City 4
Milan 4
Modena 4
Santa Clara 4
The Dalles 4
Abidjan 3
Hanoi 3
New York 3
Amsterdam 2
Bengaluru 2
Chicago 2
Jakarta 2
Lappeenranta 2
Lauterbourg 2
Marano Vicentino 2
Montreal 2
Munich 2
Poznan 2
Rome 2
Seoul 2
The Hague 2
Tokyo 2
Toronto 2
Agadir 1
Akola 1
Al Mansurah 1
Ankara 1
Atlanta 1
Baghdad 1
Barnet 1
Biñan 1
Charlotte 1
Chennai 1
Clifton 1
Curitiba 1
Dallas 1
Denver 1
Easley 1
Fort Worth 1
Frankfurt am Main 1
Goiânia 1
Guangzhou 1
Hangzhou 1
Helsinki 1
Hillsboro 1
Hortolândia 1
Huế 1
Hải Dương 1
Igarapé Miri 1
Ijuí 1
Itajobi 1
Izmir 1
Korçë 1
Lages 1
Las Heras 1
Las Vegas 1
Lecce 1
Leopoldo de Bulhões 1
Media 1
Memphis 1
Mexico City 1
Nuremberg 1
Panama City 1
Paragominas 1
Perth 1
Phủ Lý 1
Pittsburg 1
Qingdao 1
Renon 1
Repentigny 1
Reston 1
Salvador 1
Shanghai 1
Shenzhen 1
São Paulo 1
Taichung 1
Vancouver 1
Vienna 1
Virginia Beach 1
Wagner 1
Xinxiang 1
Zurich 1
Totale 216
Nome #
Clinical efficacy of the first two doses of anti-SARS-CoV-2 mRNA vaccines in solid cancer patients 167
Lenvatinib in advanced thyroid, salivary gland, endometrial, and hepatocellular carcinomas: a real-world study on treatment duration and toxicity management 78
Effectiveness comparison of first-line CDK4/6 inhibitors in patients with hormone-positive HER2-negative advanced breast cancer according to tumor histology: a sub-analysis of the real-world, multicenter, Italian study PALMARES-2 78
Real-world effectiveness of PARP inhibitors after CDK4/6 inhibitor therapy in BRCA-mutated HR-positive/HER2-negative advanced breast cancer 13
PARPi effectiveness after CDK4/6i in BRCA1- and BRCA2-associated HR+/HER2- advanced breast cancer: Results from the multicenter real-world PAMBRACA study 2
Effectiveness comparison of first-line CDK4/6 inhibitors in patients with hormone-positive HER2-negative advanced breast cancer according to tumor histology: a sub-analysis of the real-world, multicenter, Italian study PALMARES-2 1
Totale 339
Categoria #
all - tutte 1.017
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.017


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202424 3 2 3 2 5 3 2 0 0 0 2 2
2024/202548 2 7 2 0 2 4 3 2 5 2 10 9
2025/2026267 13 10 12 20 12 12 23 19 43 32 44 27
Totale 339